Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint

Fig. 2

Vaccine-induced SARS-CoV-2 neutralizing antibody response by time period and natural-infection-induced neutralizing antibody response for convalescent patients in clinical trials. A mRNA-1273, B BNT162b2, C NVX-CoV2373, D V01, and E CoronaVac. The number on the top of the bar represents the GMT, and the vertical line represents the 95% confidence interval. The confidence interval of neutralizing antibody level for NVX-CoV2373 and V01 were digitally extracted from pictures. The neutralization assay for mRNA-1273 was a pseudovirus neutralization assay, while live virus neutralization assays were used for the other vaccines

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us